← Evidence map

ReviewCurrent treatment options in oncology2023

CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed?

Elizabeth Sakach et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 37314645